Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preliminary Placebo-Controlled Double-Blind Randomized Clinical Trial of Mobile Platform to Improve Memory From Home or Office for Patients With Schizophrenia

NCT07659938 is registered in ClinicalTrials.gov with BioSignal Solutions LLC as lead sponsor.

NCT NCT07659938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07659938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preliminary Placebo-Controlled Double-Blind Randomized Clinical Trial of Mobile Platform to Improve Memory From Home or Office for Patients With Schizophrenia
Lead sponsor
BioSignal Solutions LLC
Phase
Not applicable
Overall status
Not yet recruiting
Start date
April 30, 2027
Completion date
June 30, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective, schizophrenia